Search Results for
A022004Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
Continue Reading »S2107
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Continue Reading »GI008
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Continue Reading »NSABP C-14
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Continue Reading »EA2201 (Suspended)
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer( Suspended)
Continue Reading »NRG-GI005 (Suspended)
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery (Suspended)
Continue Reading »S1820
Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors
Continue Reading »WF-1806
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Continue Reading »